CVS $315M settlement terms
Oct 15, 2026 – Oct 25, 2026
-
CVS Pharmacy settles DOJ opioid dispensing lawsuit for $315 million under the False Claims Act and Controlled Substances Act
The Justice Department announced October 13 that CVS agreed to pay $315 million to resolve a 2024 civil suit alleging pharmacists filled unlawful opioid prescriptions billed to Medicaid and other federal programs, with the government contending that short staffing and volume-based incentive pay drove dispensing without legitimacy checks.
Read this issue → -
CVS agrees to $315M controlled-substance settlement
CVS agreed to pay $315 million to resolve Justice Department allegations that it illegally filled controlled-substance prescriptions from October 2013 to December 2025 and billed federal programs, and signed a DEA agreement requiring a reporting hotline and dispensing monitoring.
Read this issue → -
CVS $315M settlement terms
CVS agreed to pay $315 million to resolve Controlled Substances Act and False Claims Act allegations over opioid fills from October 2013 to December 2025 and signed a DEA memorandum of agreement, with no determination of liability.
Read this issue →